Whole Cell Cholera Vaccine Market
Whole Cell Cholera Vaccine Market Size, Share & Trends Analysis Report
Whole Cell Cholera Vaccine Market Size, Share, Statistics & Trends Analysis Report By Type (Adult, Children), By End-User (Clinical Research Institutes, Hospital, Surgical centers), Based On Region, And Segment Forecasts, 2022 – 2029
Published
Report ID : BMRC 2288
Number of pages : 300
Published Date : Jan 2023
Category : Vaccines
Delivery Timeline : 48 hrs
Key Players
- SBL Vaccine
- PaxVax,Inc.
- Valneva SE
- GlaxoSmithKline Plc.
- Johnson and Johnson
- Sanofi
- Merck and Co. Inc.
- Pfizer Inc.
- AstraZeneca Plc.(Medimmune, LLC.)
- Serum Institute of India Pvt.Ltd.
Segmentations:
By Type
- Adult
- Children
By End-User
- Clinical Research Institutes
- Hospital
- Surgical centers
SUMMARY
Segments
By Type
- Adult
- Children
By End-User
- Clinical Research Institutes
- Hospital
- Surgical centers
Regions and Country
North America
- U.S.
- Canada
Europe
- Germany
- France
- U.K.
- Italy
- Spain
- Sweden
- Netherlands
- Turkey
- Switzerland
- Belgium
- Rest of Europe
Asia-Pacific
- South Korea
- Japan
- China
- India
- Australia
- Philippines
- Singapore
- Malaysia
- Thailand
- Indonesia
- Rest of APAC
Latin America
- Mexico
- Colombia
- Brazil
- Argentina
- Peru
- Rest of South America
Middle East and Africa
- Saudi Arabia
- UAE
- Egypt
- South Africa
- Rest of MEA
Key Players
- SBL Vaccine
- PaxVax,Inc.
- Valneva SE
- GlaxoSmithKline Plc.
- Johnson and Johnson
- Sanofi
- Merck and Co. Inc.
- Pfizer Inc.
- AstraZeneca Plc.(Medimmune, LLC.)
- Serum Institute of India Pvt.Ltd.
